Treatment monitoring

Blood Transcriptomic Signatures as Predictors of Poor Outcomes in Drug-Susceptible Pulmonary Tuberculosis: Insights from a Brazilian Cohort

By MedXY 09/17/2026

Host blood transcriptomic signatures effectively monitor treatment response and predict recurrence and mortality in drug-susceptible pulmonary tuberculosis, meeting WHO benchmarks and enabling personalized therapy strategies.

Clinical Updates Neurology news

Refining Treatment Monitoring in Patients With Relapsing Multiple Sclerosis Based on Changes on Neurofilament Light Chain Z-Scores

By MedXY 08/21/2026

Serum neurofilament light chain (sNfL) z-score dynamics enhance monitoring of treatment response in relapsing multiple sclerosis (RMS), providing complementary predictive value for disease activity beyond conventional clinical and MRI assessments.

news Otorhinolaryngology

Evaluating Automated Acoustic Metrics for Monitoring Botulinum Toxin Treatment in Adductor Laryngeal Dystonia

By MedXY 08/11/2026

This article reviews the utility of pitch strength and percent vocal creak as automated acoustic biomarkers to assess treatment response in adductor laryngeal dystonia, highlighting their correlations with traditional measures yet limited group-level sensitivity.